Healthy Skepticism Library
Items published during the years 1980 to 1989
There are 1082 items in the Healthy Skepticism Library that were published during the years 1980 to 1989.
Page 6 of 11 pages ‹ First < 4 5 6 7 8 > Last ›
HSL9611
Harvey KJ, Stewart R, Hemming M, Naismith N, Moulds RF.
Educational antibiotic advertising.
Med J Aust 1986 Jul 7; 145:(1):28-32
HSL3390
Re: the promotion of diphenhydramine and ammonium chloride
1986 Jul;
HSL3391
Pierpaoli PG.
ASHP's position on direct-to-consumer advertising of prescription drug products.
Am J Hosp Pharm 1986 Jul; 43:(7):1763-5
HSL9641
Programmed-delivery products revitalize markets for old drugs, report says
American Journal of Hospital Pharmacy 1986 Jul; 43:1645-1646
HSL9643
Commodity generic sales in 1985 grew 50% over 1984, says report on generic drug industry
American Journal of Hospital Pharmacy 1986 Jul; 43:1644
HSL9648
Concerning the case of: United States v. American Pharmaceutical Association and Michigan State Pharmaceutical Association, Civil No. G75-558 CA5, W.D. Michigan
Journal Michigan Pharmacist 1986 Jul; 24:14-15
HSL3341
Greenhalgh T.
Drug marketing in the Third World: beneath the cosmetic reforms.
Lancet 1986 Jun 7; 1:(8493):1318-20
HSL9639
Cusick JJ, Downs GE.
Prescription to over-the-counter switch
American Druggist 1986 Jun; 193:101-107, 113
HSL9642
McCarthy R.
Dingell subcommittee would ban physical sampling
American Druggist 1986 Jun; 193:12, 17
HSL20477
Haslam A
Doctor on warpath
New Sunday Times 1986 May 4
HSL3337
Davidson RA.
Source of funding and outcome of clinical trials.
J Gen Intern Med 1986 May-Jun; 1:(3):155-8
HSL9629
Lord R.
Reye's syndrome and aspirin-industry's position
Australian Journal of Pharmacy 1986 May; 67:518, 520, 522
HSL9654
Cardinale V.
Industry leaders extend hand in fair pricing
Drug Topics 1986 Apr 21; 130:18, 20, 22
HSL3359
McCue JD, Hansen CJ, Gal P.
Physicians' opinions of the accuracy, accessibility, and frequency of use of ten sources of new drug information.
South Med J 1986 Apr; 79:(4):441-3
HSL3388
Re: the promotion of Rheopyrine
1986 Apr;
HSL9623
Woodhouse RJ.
UK prescribing limits begin to take toll
Drug Cosmet Ind 1986 Apr; 138:50, 52, 104-105
HSL9647
FDA speaks out about generic drug quality
National Association of Boards of Pharmacy Newsletter 1986 Apr; 15:53-54
HSL9651
Commerce Department predicts gains in pharmacist prescribing
American Pharmacy 1986 Apr; 26:20
HSL9655
Mossinghoff GJ.
Drug price increase explained.
Am Pharm 1986 Apr; NS26:(4):5-6
HSL9646
Drug search: meshing costs, regs
Medical World News 1986 Mar 10; 27:114-115
HSL3375
Spiro HM.
Mammon and medicine. The rewards of clinical trials
JAMA. 1986 Mar 7;255(9):1174-5 1986 Mar 07; 255:(9):1174-5
HSL3386
Re: the promotion of Primobolan and Fortabol
1986 Mar;
HSL3387
To what extent should pharmaceutical houses advertise to the public?
Pharmacy Times 1986 Mar; 52:(3):86-88, 90, 93
HSL9649
Kushner D.
Don't advertise Rx drugs to public, mfrs are urged
American Druggist 1986 Mar; 193:126, 128, 130, 132
HSL9662
To what extent should pharmaceutical houses advertise to the public?
Pharmacy Times 1986 Mar; 52:86-88, 90, 93
HSL9661
Robinson B.
Consumer Rx ads viewed warily by pharmacists
Drug Topics 1986 Feb 17; 130:94, 96
HSL9659
Robinson B.
Consumer Rx ads edge closer to reality
Drug Topics 1986 Feb 3; 130:42
HSL3385
Re: the promotion of ibuprofen syrup
1986 Feb;
HSL9638
Radoczy G.
Formulae Normales
Gyogyszereszet 1986 Feb; 30:59-62
HSL9656
Cramer PK.
Measuring the marketing clout of postmarketing clinical studies
Pharmaceutical Executive 1986 Feb; 6:54-55, 57
HSL9660
To keep drugs cost effective, industry told to look at compliance
American Pharmacy 1986 Feb; 26:7
HSL3355
Mahood CB, Rothwell RP, Holford N.
Slow-release theophylline (THEO-24)
N Z Med J. 1986 Jan 22; 99:(794):21
HSL9653
Debenedette V.
CBS ready for Rx ads
Med Advert News 1986 Jan 15; 5:1, 37-38
HSL861
Mansfield P.
Phenylbutazone.
Med J Aust 1986 Jan 6; 144:(1):55
HSL20475
Mansfield PR
Phenylbutazone
Medical Journal of Australia 1986 Jan 6; 144:55
HSL3363
Morris LA, Brinberg D, Klimberg R, Rivera C, Millstein LG.
The attitudes of consumers toward direct advertising of prescription drugs.
Public Health Rep 1986 Jan-Feb; 101:(1):82-9
HSL3384
How physicians feel about Rx drug product ads beamed at the public
Pharmacy Times 1986 Jan; 52:(1):85-88, 91-92
HSL8351
How physicians feel about Rx drug product ads beamed at the public
Pharmacy Times 1986 Jan; 52:85-88, 91-92
HSL9594
Pollock CL.
Advertising prescription drugs to the public: who benefits?
DO 1986 Jan; 27:111-116
HSL9597
Sandrick K.
Generics: moving in on the prescription drug market
DO 1986 Jan; 27:85-88
HSL9650
Discriminatory pricing: attacking prescription drug diversion at its source
National Association of Retail Druggists Journal 1986 Jan; 108:16-18, 28
HSL2059
Goldman R, Montagne M.
Marketing 'mind mechanics': decoding antidepressant drug advertisements.
Soc Sci Med 1986; 22:(10):1047-58
HSL3315
Bayer UK Ltd suspended over actions by representatives
Pharmaceutical Journal 1986; 237:821-822
HSL3316
Charges against Roussel Laboratories concerning advertisements
Lancet 1986; 1:112
HSL3317
Congressional panel wants to ban drug samples
Canadian Medical Association Journal 1986; 134:1302
HSL3318
Need for a rational drugs policy
Lancet 1986; 1:262
HSL3320
Akin GM.
The ethics of pharmaceutical promotion
New England Journal of Medicine 1986; 315:590
HSL3321
Anand MP.
Marketing drugs in the Third World
Lancet 1986; 2:222
HSL3322
Bader M.
Advertising prescription drugs to the public
New England Journal of Medicine 1986; 314:523
HSL3323
Bearn AG.
Should a drug company employee edit a medical journal?
Lancet 1986; 1:974
HSL3324
Bhattacharjee PK.
Marketing drugs in the Third World
Lancet 1986; 2:576
HSL3325
Blum AL, Chalmers TC, Deutsch E, Koch-weser J, Langman M, Rosen A, Tygstrup N, Zentgraf R.
Differing attitudes of industry and academia towards controlled clinical trials
European Journal of Clinical Investigation 1986; 16:455-460
HSL3326
Blumenthal D, Gluck M, Louis KS, Stoto MA, Wise D.
University-industry research relationships in biotechnology: implications for the university
Science 1986; 232:1361-1366
HSL3328
Burley DM.
Should a drug company employee edit a medical journal?
Lancet 1986; 1:(801):
HSL3329
Cairns L.
Offensive advertising?
New Zealand Medical Journal 1986; 99:641-642
HSL3330
Guidelines for drug-company-supported CME
Canadian Medical Association Journal 1986; 135:384A
HSL3332
Cohen RL.
Drug companies and journal supplements
Lancet 1986; 1:1157
HSL3333
Collins GL.
Prescription drug advertising: a medical view
Journal of Pharmaceutical Marketing & Management 1986; 1:(2):19-22
HSL3334
Comanor WS.
The political economy of the pharmaceutical industry.
J Econ Lit 1986; 24:(3):1178-1217
HSL3335
Drugs and the Third World: chloroform sale and hazards—a Malaysian study
Consumers’ Association of Penang 1986;
HSL3336
Cramer R.
Information responsibilities of generic drug companies
American Journal of Hospital Pharmacy 1986; 43:1674-1675
HSL3338
Dingell JD.
Advertising prescription drugs to the public
New England Journal of Medicine 1986; 314:524
HSL3340
Feather KR.
Direct to the consumer advertising—how close can we come?
Journal of Pharmaceutical Marketing & Management 1986; 1:(2):67-71
HSL3342
Greenhalgh T.
Marketing drugs in the Third World
Lancet 1986; 2:222
HSL3343
Henderson AM.
The CBS consumer model
Journal of Pharmaceutical Marketing & Management 1986; 1:(2):7-11
HSL3345
Kerr HD, Brobny EC.
Advertising prescription drugs to the public
New England Journal of Medicine 1986; 314:523-524
HSL3346
Lapinski F.
Omission of women and black physicians from Journal ads
New England Journal of Medicine 1986; 314:653
HSL3350
Lavizzo-mourey R.
Medications and the elderly
Journal of Pharmaceutical Marketing & Management 1986; 1:(2):45-50
HSL3351
Lee A.
Marketing drugs in the Third World
Lancet 1986; 2:222
HSL3352
Leigh AP.
Should a drug company employee edit a medical journal?
Lancet 1986; 1:974
HSL3353
Lipton C.
Consumer advertising and pharmaceuticals: a happy marriage?
Journal of Pharmaceutical Marketing & Management 1986; 1:(2):23-28
HSL3354
Mac Sheoin T.
Unethical behavior in an ethical industry? Critical coverage of the pharmaceutical industry, 1983-1984
International Journal of Health Services 1986; 16:141-162
HSL3356
Mamdani M, Walker G.
Essential drugs in the developing world
Health Policy and Planning 1986; 1:187-201
HSL3357
Masson A, Rubin PH.
Advertising prescription drugs to the public
New England Journal of Medicine 1986; 314:524
HSL3358
Masson A, Rubin PH.
Warning: brief summaries may be hazardous to your health (and wealth) or the real issues in prescription drug advertising to consumers
Journal of Pharmaceutical Marketing & Management 1986; 1:(2):29-43
HSL3360
McGovern I.
Advertising and benzodiazepines
Medical Journal of Australia 1986; 145:179
HSL3361
McMahon FG.
Advertising prescription drugs to the public
New England Journal of Medicine 1986; 314:524
HSL3362
Moench EA.
The Boots advertising campaign
Journal of Pharmaceutical Marketing & Management 1986; 1:(2):51-55
HSL3364
Morris LA, Brinberg D, Klimberg R, Millstein L, Rivera C.
Consumer attitudes about advertisements for medicinal drugs.
Soc Sci Med 1986; 22:(6):629-38
HSL3367
O’brien M.
Advertising prescription drugs to the public
New England Journal of Medicine 1986; 314:523
HSL3368
Perkin RL.
The pharmaceutical industry
Canadian Family Physician 1986; 32:2013
HSL3369
Rockwell T.
The Lifetime experience with prescription drug advertising exposed to consumers
Journal of Pharmaceutical Marketing & Management 1986; 1:(2):13-18
HSL3370
Roseman EP.
Checking the scorecard
Medical Marketing & Media 1986; 21:(10):40, 42, 44
HSL3372
Schueler KR.
Direct-to-consumer promotion
Journal of Pharmaceutical Marketing & Management 1986; 1:(2):57-65
HSL3373
Silverman M, Lee PR, Lydecker M.
Drug promotion: the Third World revisited.
Int J Health Serv 1986; 16:(4):659-67
HSL3376
St. George
Effects of medical research on life expectancy
Lancet 1986; 2:517
HSL3378
Stavem P.
Should a drug company employee edit a medical journal?
Lancet 1986; 1:684
HSL3380
Turner J.
Antibiotic conference cancelled for second time
Lancet 1986; 1:333
HSL3381
Vener AM, Krupka LR.
Over-the-counter drug advertising in gender oriented popular magazines.
J Drug Educ 1986; 16:(4):367-81
HSL3383
Woods D.
PMAC to spend almost $1 million annually to reach “stakeholders”
Canadian Medical Association Journal 1986; 134:1387, 1389
HSL3389
Rothschild M.
Death by prescription
The Progressive 1986; 50:(6):18, 20-22
HSL3409
Collier J.
Promotion of medicines—the failure of regulation
Medicine in Society 1986; 12:(3):8-10
HSL9061
McDonnell K
Adverse Effects - Women and the Pharmaceutical Industry
: Canadian Scholars Press 1986
http://www.amazon.ca/Adverse-effects-Women-pharmaceutical-industry/dp/0889611084
HSL9609
Laroche M, Rosenblatt J, Wahler L, Bliemel F.
Economic considerations for dispensing pharmacists: the impact of price-quality evaluations on brand categorization.
J Pharm Mark Manage 1986 Fal; 1:(1):41-60
HSL9632
Von-breitenbach G.
German pharmaceutical industry abroad. Part 2
Drugs Made in Germany 1986; 29:(2):63-67
HSL9636
Lowenthal W, Klein WS 3rd, Overton CP.
Thinking about ethical dilemmas in pharmacy.
Am J Pharm Educ 1986 Sum; 50:(2):161-4
HSL13283
Holbrook MB, Lehmann DR, O'Shaughnessy J.
Using versus Choosing: The Relationship of the Consumption Experience to Reasons for Purchasing.
European Journal of Marketing 1986; 20:(8):49-62
http://www.ingentaconnect.com/content/mcb/007
HSL16525
Bowman MA
The impact of drug company funding on the content of continuing medical education.
Möbius 1986; 6:(1):66-69
HSL16714
Wolfe S
Letter to the Editor on safety of piroxicam
Lancet 1986; 8510:808-809
HSL9668
Robinson B.
PMA chief sees pattern of cooperation with pharmacy
Drug Topics 1985 Dec 9; 129:12-13
Page 6 of 11 pages ‹ First < 4 5 6 7 8 > Last ›
